Clinical significance of hepatitis C antibodies in blood donors

E Kolho1, M Färkkilä, J Mäkinen

  • 1Finnish Red Cross Blood Transfusion Service, Helsinki.

Insights

Hepatitis C antibody positive blood donors showed significant liver damage, with 55% having chronic persistent hepatitis and 45% active hepatitis. Indeterminate results rarely indicated liver issues.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis C virus (HCV) screening in blood donors is crucial for public health.
  • Understanding the clinical significance of anti-HCV in healthy populations requires further investigation.
  • First-generation enzyme-linked immunosorbent assays (ELISA) and second-generation recombinant immunoblot assays (RIBA-4) are key diagnostic tools.

Purpose of the Study:

  • To assess the clinical significance of hepatitis C antibodies (anti-HCV) in blood donors.
  • To determine the prevalence of liver damage in anti-HCV positive and indeterminate individuals.
  • To correlate serological findings with liver function tests and biopsy results.

Main Methods:

  • Analysis of liver function tests (ALT) and liver biopsies in blood donors screened for anti-HCV.
  • Monitoring of alanine aminotransferase (ALT) levels in RIBA-4 positive and indeterminate donors.
  • Measurement of serum N-terminal type III procollagen (PIIINP) and polymerase chain reaction (PCR) for hepatitis C confirmation.

Main Results:

  • Among 307,606 donors, 195 were anti-HCV positive or indeterminate.
  • 25 (37.3%) of RIBA-4 positive donors had elevated ALT levels, compared to 1.6% of RIBA-4 indeterminate donors (P < 0.0005).
  • Of 20 RIBA-4 positive donors with elevated ALT who underwent biopsy, 55% had chronic persistent hepatitis and 45% had chronic active hepatitis (mild to severe).

Conclusions:

  • Anti-HCV positivity in blood donors is strongly associated with significant liver damage.
  • Liver biopsies confirm a high prevalence of chronic hepatitis among seropositive individuals.
  • Indeterminate anti-HCV results in donors rarely indicate active liver disease.

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Blood Typing01:10

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...